PROCLAIM
Showing 1 - 25 of 29
Prostate Cancer Trial in United States (Invitae multi-cancer gene panel)
Completed
- Prostate Cancer
- Invitae multi-cancer gene panel
-
San Diego, California
- +18 more
Jul 1, 2022
Clostridium Difficile Trial in Saint Louis, Chapel Hill, Nashville (Misoprostol 100Mcg Tab, Placebo)
Completed
- Clostridium Difficile
- Misoprostol 100Mcg Tab
- Placebo
-
Saint Louis, Missouri
- +2 more
Mar 2, 2022
Parkinson Disease Trial in New York, Houston (Spinal Cord Stimulator (SCS))
Recruiting
- Parkinson Disease
- Spinal Cord Stimulator (SCS)
-
New York, New York
- +1 more
Apr 18, 2022
Peripheral Neuropathic Pain, Radiculopathy, Lower Back Pain Trial in Oslo, Uppsala (Burst SCS (Abbott Proclaim IPG and single
Recruiting
- Peripheral Neuropathic Pain
- +2 more
- Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10)
-
Oslo, Norway
- +1 more
Sep 6, 2021
Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)
Terminated
- Solid Tumor
- Unresectable or Metastatic Melanoma
-
Duarte, California
- +26 more
Nov 2, 2021
TARGET Post-Approval Study
Active, not recruiting
- Complex Regional Pain Syndrome (CRPS)
- Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System)
- Dorsal Root Ganglion (DRG) Stimulation (Proclaim™ Neurostimulator System)
-
Scottsdale, Arizona
- +44 more
Apr 6, 2022
FBSS, Pain, Intractable, Low Back Pain Trial in Uppsala (Proclaim™ Elite 5: Burst - Washout - Sham, Proclaim™ Elite 5: Sham -
Unknown status
- FBSS
- +3 more
- Proclaim™ Elite 5: Burst - Washout - Sham
- Proclaim™ Elite 5: Sham - Washout - Burst
-
Uppsala, SwedenUppsala University Hospital, Uppsala University, Dept. of Surgic
Apr 7, 2020
Chronic Low-Back Pain, Refractory Pain, Neuropathic Pain Trial in United States (Spinal Cord Stimulation, Comprehensive Medical
Active, not recruiting
- Chronic Low-Back Pain
- +2 more
- Spinal Cord Stimulation
- Comprehensive Medical Management
-
Phoenix, Arizona
- +31 more
Apr 6, 2022
Chronic Pain, Intractable Pain Trial in Worldwide (Prodigy, Prodigy MRI or Proclaim Elite IPG)
Completed
- Chronic Pain
- Intractable Pain
- Prodigy, Prodigy MRI or Proclaim Elite IPG
-
Phoenix, Arizona
- +21 more
Jul 7, 2021
Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Romiplostim
- Placebo
-
Jonesboro, Arkansas
- +107 more
Feb 1, 2023
Chronic Pain Trial in Antwerpen, Duisburg, Düsseldorf (Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal
Completed
- Chronic Pain
- Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol
-
Antwerpen, Belgium
- +2 more
May 17, 2019
Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)
Active, not recruiting
- Kidney Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022
Pelvic Surgery, Routine Fallopian Tube Removal Trial in Baden, Bern (Routine fallopian tube removal)
Recruiting
- Pelvic Surgery
- Routine Fallopian Tube Removal
- Routine fallopian tube removal
-
Baden, Switzerland
- +1 more
Sep 29, 2021
Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis Trial in New York (Dorsal Root Ganglion Stimulation)
Recruiting
- Knee Osteoarthritis
- +3 more
- Dorsal Root Ganglion Stimulation
-
New York, New YorkThe Spine and Pain Institute of New York
Apr 29, 2022
CRPS (Complex Regional Pain Syndromes), Radiculopathy, Peripheral Neuropathy Trial (DRG stimulation 20 Hz 30/90, DRG stimulation
Not yet recruiting
- CRPS (Complex Regional Pain Syndromes)
- +2 more
- DRG stimulation 20 Hz 30/90
- DRG stimulation 5 Hz 30/90
- (no location specified)
Apr 18, 2022
Metastatic Melanoma Trial in United States (High Dose Interleukin-2, Ipilimumab)
Terminated
- Metastatic Melanoma
- High Dose Interleukin-2
- Ipilimumab
-
Tucson, Arizona
- +11 more
Dec 1, 2020
Poor Response to Monoclonal Therapy in Asthma
Recruiting
- Asthma
- Anti-IL5 Antibody
- Bronchoscopy
-
Nottingham, United KingdomNottingham Respiratory BRU
Nov 2, 2020
Treatment Patterns and Clinical Response in Malignancy
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
-
Tucson, Arizona
- +44 more
Jun 11, 2019
Chronic Pain Trial in United States (Burst-capable SCS system, DRG Stimulator)
Completed
- Chronic Pain
- Burst-capable SCS system
- DRG Stimulator
-
Camarillo, California
- +18 more
Mar 3, 2022
NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus
Recruiting
- Non-small Cell Lung Cancer Stage III
- durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
- +2 more
-
Paris, France
- +2 more
May 30, 2022
Discogenic Pain, Low Back Pain Trial in Arnhem (Neurostimulation)
Active, not recruiting
- Discogenic Pain
- Low Back Pain
- Neurostimulation
-
Arnhem, Gelderland, NetherlandsRijnstate hospital Pain Management Centre Velp
Mar 10, 2021